Nijmegen breakage syndrome: The clearance pathway for mutant nibrin protein is allele specific

Gene

Volumn 519, Issue 2, 2013, Pages 217-221

  Salewsky, Bastian ^a   Wessendorf, Petra ^a   Hirsch, Daniel ^a   Krenzlin, Harald ^a   Digweed, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

DNA repair; Lysosome; Microautophagy; Proteasome

Indexed keywords

ARGININE; COMPLEMENTARY DNA; NIBRIN; PROTEASOME; TRYPTOPHAN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; FIBROBLAST; HUMAN; IMMUNOBLOTTING; LYSOSOME; MICROAUTOPHAGY; MISSENSE MUTATION; NIJMEGEN BREAKAGE SYNDROME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; AMINO ACID SUBSTITUTION; AUTOPHAGY; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; GENETIC MARKERS; GENETIC VECTORS; HUMANS; KINETICS; MUTANT PROTEINS; MUTATION, MISSENSE; NIJMEGEN BREAKAGE SYNDROME; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; RETROVIRIDAE;

EID: 84875587226     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.033     Document Type: Article

References (39)

1. Adzhubei I.A., et al. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Bartek J., Lukas J., Bartkova J. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle 2007, 6:2344-2347.
3. Bejarano E., Cuervo A.M. Chaperone-mediated autophagy. Proc. Am. Thorac. Soc. 2010, 7:29-39.
4. Bogdanova N., et al. Nijmegen breakage syndrome mutations and risk of breast cancer. Int. J. Cancer 2008, 122:802-806.
5. Carney J.P., et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998, 93:477-486.
6. Cerosaletti K.M., Desai-Mehta A., Yeo T.C., Kraakman-Van Der Zwet M., Zdzienicka M.Z., Concannon P. Retroviral expression of the NBS1 gene in cultured Nijmegen breakage syndrome cells restores normal radiation sensitivity and nuclear focus formation. Mutagenesis 2000, 15:281-286.
7. Chen Y.C., et al. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 2005, 280:32505-32511.
8. Chrzanowska K.H., Gregorek H., Dembowska-Baginska B., Kalina M.A., Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J. Rare Dis. 2012, 7:13.
9. Crosslin D.R., et al. Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum. Genet. 2012, 131:639-652.
10. Demuth I., Digweed M. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene 2007, 26:7792-7798.
11. Demuth I., et al. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum. Mol. Genet. 2004, 13:2385-2397.
12. di Masi A., Viganotti M., Polticelli F., Ascenzi P., Tanzarella C., Antoccia A. The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. Biochem. Biophys. Res. Commun. 2008, 369:835-840.
13. Difilippantonio S., et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol. 2005, 7:675-685.
14. Dumon-Jones V., et al. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res. 2003, 63:7263-7269.
15. Gonzalez-Noriega A., Grubb J.H., Talkad V., Sly W.S. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. J. Cell Biol. 1980, 85:839-852.
16. Goodarzi A.A., et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 2008, 31:167-177.
17. Gragnoli C. Proteasome modulator 9 SNPs are linked to hypertension in type 2 diabetes families. Cardiovasc. Diabetol. 2011, 10:77.
18. Kanu N., Behrens A. ATMINistrating ATM signalling: regulation of ATM by ATMIN. Cell Cycle 2008, 7:3483-3486.
19. Komatsu K., et al. The gene for Nijmegen breakage syndrome (V2) is not located on chromosome 11. Am. J. Hum. Genet. 1996, 58:885-888.
20. Kraakman-van der Zwet M., et al. Immortalization and characterization of Nijmegen breakage syndrome fibroblasts. Mutat. Res. 1999, 434:17-27.
21. Kracker S., et al. Nibrin functions in Ig class-switch recombination. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1584-1589.
22. Kruger L., et al. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis 2007, 28:107-111.
23. Lee J.H., Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004, 304:93-96.
24. Lins S., Kim R., Kruger L., Chrzanowska K.H., Seemanova E., Digweed M. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen breakage syndrome. Gene 2009, 447:12-17.
25. Loehberg C.R., et al. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis. Cancer Res. 2007, 67:12026-12033.
26. Maser R.S., Zinkel R., Petrini J.H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat. Genet. 2001, 27:417-421.
27. Matsuoka S., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
28. Mijaljica D., Prescott M., Devenish R.J. Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. Autophagy 2011, 7:673-682.
29. Okada Y., et al. Common variations in PSMD3-CSF3 and PLCB4 are associated with neutrophil count. Hum. Mol. Genet. 2010, 19:2079-2085.
30. Roberts P., Moshitch-Moshkovitz S., Kvam E., O'Toole E., Winey M., Goldfarb D.S. Piecemeal microautophagy of nucleus in Saccharomyces cerevisiae. Mol. Biol. Cell 2003, 14:129-141.
31. Seemanova E., et al. Cancer risk of heterozygotes with the NBN founder mutation. J. Natl. Cancer Inst. 2007, 99:1875-1880.
32. Seemanova E., et al. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J. Med. Genet. 2006, 43:218-224.
33. Steffen J., Maneva G., Poplawska L., Varon R., Mioduszewska O., Sperling K. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation. Int. J. Cancer 2006, 119:2970-2973.
34. Steffen J., et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int. J. Cancer 2004, 111:67-71.
35. Taylor G.M., O'Brien H.P., Greaves M.F., Ravetto P.F., Eden O.B. Correspondence re: R. Varon et al., mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res. 2003, 61:3570-3572.
36. Cancer Res. 2001, 63:6563-6564. (author reply 6565).
37. van Engelen B.G., Hiel J.A., Gabreels F.J., van den Heuvel L.P., van Gent D.C., Weemaes C.M. Decreased immunoglobulin class switching in Nijmegen breakage syndrome due to the DNA repair defect. Hum. Immunol. 2001, 62:1324-1327.
38. Varon R., et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998, 93:467-476.
39. Williams R.S., et al. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 2009, 139:87-99.